Sammy Ghazal brings over 20 years of experience across the MedTech and diagnostics sector, supporting international healthcare companies entering and expanding across Middle East and North Africa markets.
He previously held senior commercial and market development roles at leading global diagnostics companies including Diasorin, Bio-Rad Laboratories, Stago, and Thermo Fisher Scientific, where he was responsible for regional expansion and partner development across Middle East growth markets.
Sammy holds a degree in Biomedical Sciences from the University of the West of England, Bristol, providing a strong scientific foundation to his commercial leadership in the diagnostics sector.
He founded Biocentric to provide specialised regional expertise to MedTech innovators navigating complex healthcare markets and establishing their commercial presence across the region.